Selective ROS-dependent p53-associated anticancer effects of the hypoxoside derivative rooperol on human teratocarcinomal cancer stem-like cells

ALI AZOUAOU, S., EMHEMMED, F., IDRIS-KHODJA, N., LOBSTEIN, A., SCHINI-KERTH, Valérie, MULLER, C. D. et FUHRMANN, Guy, 2015. Selective ROS-dependent p53-associated anticancer effects of the hypoxoside derivative rooperol on human teratocarcinomal cancer stem-like cells. Investigational New Drugs [en ligne]. 2015. Vol. 33, n° 1pp. 64-74. [Consultésans date]. DOI 10.1007/s10637-014-0182-6. Consulté de : http://www.ncbi.nlm.nih.gov/pubmed/25404486